0001144204-07-015846 Sample Contracts

Contract
Calypte Biomedical Corp • April 2nd, 2007 • Laboratory analytical instruments

NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

AutoNDA by SimpleDocs
SUBSCRIPTION AGREEMENT
Subscription Agreement • April 2nd, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Oregon

This SUBSCRIPTION AGREEMENT (the "Agreement") is made by and between the subscriber hereto (the “Subscriber”) and Calypte Biomedical Corporation, a Delaware corporation (the "Company”).

SIXTH AMENDMENT TO 2005 CREDIT FACILITY
Credit Facility Agreement • April 2nd, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware

THIS SIXTH AMENDMENT TO 2005 CREDIT FACILITY AGREEMENT (this "Amendment") is made as of March 21, 2007, by and among Calypte Biomedical Corporation, a Delaware corporation ("Issuer"), and Marr Technologies, BV, a limited liability company established in the Netherlands ("Purchaser"). Unless otherwise defined herein, all capitalized terms used herein shall have the meanings given to them in the Credit Facility referred to below.

AMENDMENT TO SECURED 8% CONVERTIBLE PROMISSORY NOTES
Securities Purchase Agreement • April 2nd, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware

THIS AMENDMENT (this "Amendment") to Secured 8% Convertible Promissory Notes (the "Notes") is made as of March 21, 2007, by and between Calypte Biomedical Corporation, a Delaware corporation (the "Company"), and Morningtown Limited, a limited liability company established in Mauritius (the “Investor”). If there is any inconsistency between the terms of this Amendment and any other agreement referenced herein, the terms of this Amendment will govern.

AMENDMENT TO SECURED 8% CONVERTIBLE PROMISSORY NOTES
Securities Purchase Agreement • April 2nd, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware

THIS AMENDMENT (this "Amendment") to Secured 8% Convertible Promissory Notes (each, a “Note,” and collectively, the "Notes") is made as of March 21, 2007, by and between Calypte Biomedical Corporation, a Delaware corporation (the "Company"), and Marr Technologies BV, a limited liability company established in the Netherlands (the “Investor”). If there is any inconsistency between the terms of this Amendment and any other agreement referenced herein, the terms of this Amendment will govern.

AMENDMENT TO SECURED 8% CONVERTIBLE PROMISSORY NOTES
Securities Purchase Agreement • April 2nd, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware

THIS AMENDMENT (this "Amendment") to Secured 8% Convertible Promissory Notes (the "Notes") is made as of March 21, 2007, by and between Calypte Biomedical Corporation, a Delaware corporation (the "Company"), and SF Capital Partners Ltd. (the “Investor”). If there is any inconsistency between the terms of this Amendment and any other agreement referenced herein, the terms of this Amendment will govern.

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • April 2nd, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Oregon

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 28, 2007, by and among Calypte Biomedical Corporation, a Delaware corporation (the “Company”), and the investors signatory hereto (each a “Investor” and collectively, the “Investors”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!